In colon cancer, TIMP1 promotes cell proliferation and metastasis by activating the FAK/PI3K/AKT pathway, and selective FAK or AKT inhibitors impair the pro-tumor effects of TIMP1.43 Here, TIMP1 is linked to malignant colon neoplasm.